Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results

Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday.  Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to…

Read More
UCLA Health launches clinical trial using personal | Newswise

UCLA Health launches clinical trial using personal | Newswise

BYLINE: Denise Heady Newswise — In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive Cancer Center are launching a first-of-its-kind clinical trial to evaluate the safety and effectiveness of a cancer vaccine targeting H3 G34-mutant diffuse hemispheric glioma, a highly aggressive brain tumor that…

Read More
Ovarian Cancer: What Every Woman Should Know | Newswise

Ovarian Cancer: What Every Woman Should Know | Newswise

Newswise — New Brunswick, N.J., September 4, 2024 –According to the American Cancer Society, ovarian cancer is one of the leading causes of cancer deaths among women. Ruth D. Stephenson, DO, FACOG, gynecologic oncologist at RWJBarnabas Health and Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, addresses five frequently asked questions…

Read More
Rutgers Receives .8 Million Federal Grant to Fun | Newswise

Rutgers Receives $4.8 Million Federal Grant to Fun | Newswise

BYLINE: Beth-Ann Kerber Newswise — New Brunswick, N.J.—A team of researchers from Rutgers Robert Wood Johnson Medical School and Rutgers Cancer Institute, has been awarded a five-year, $4.83 million grant from the National Cancer Institute (NCI) to support efforts in coordinating care for cancer survivors who are managing cardiovascular risks. Led by Denalee M. O’Malley,…

Read More
Celebrating 25 Years of Innovative Cancer Research | Newswise

Celebrating 25 Years of Innovative Cancer Research | Newswise

Newswise — On September 13, 2024, Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, celebrates 25 years of groundbreaking cancer research, education, and patient care. Since opening its doors in 1999, Huntsman Cancer Institute has made significant contributions to cancer prevention and treatment, saving lives and…

Read More